Process for modifying drug crystal formation

Details for Australian Patent Application No. 2010200756 (hide)

Owner Novartis AG

Inventors Pfeffer, Sabine; Wieckhusen, Dierk

Agent Davies Collison Cave

Pub. Number AU-A-2010200756

Parent 2007202693

Filing date 1 March 2010

Wipo publication date 18 March 2010

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

C07D 307/88 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

18 March 2010 Application Open to Public Inspection

  Published as AU-A-2010200756

18 March 2010 Complete Application Filed

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200757-Water diversion system

2010200755-Biomarker panel for colorectal cancer